Weight loss drug recalled after foreign pills found in bottles

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

GlaxoSmithKline Headquarters

NEW YORK (CNNMoney) — Alli, a popular over-the-counter weight loss drug, is being recalled in the United States and Puerto Rico because of possible tampering

GlaxoSmithKline, the British company that makes the drug, said in a statement Thursday the recall comes after complaints from customers in seven states.

“A range of tablets and capsules of various shapes and colors were reported to be found inside bottles,” the company said. “Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic.”

The statement did not disclose if anyone was harmed by the tampered product, and company officials were not immediately available for comment.

GlaxoSmithKline described authentic Alli as a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat,” which is the active compound that prevents the absorption of fat.

The London-based company said the questionable Alli was purchased in retail stores in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas. The company said it’s conducting an investigation with the Food and Drug Administration.

Back in 2010, the FDA warned that a counterfeit version of Alli that was being sold online was potentially harmful to dieters.